Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Autoimmune Disorders

  Free Subscription


08.01.2024

1 Am J Kidney Dis
2 BMC Neurol
1 Intern Med
1 J Autoimmun
1 J Clin Endocrinol Metab
3 J Immunol
3 J Neuroimmunol
2 J Neurol
1 Mult Scler
2 N Engl J Med
2 Neurologia (Engl Ed)
14 Neurology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Kidney Dis

  1. MASSICOTTE-AZARNIOUCH D, Detwiler RK, Hu Y, Falk RJ, et al
    Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis.
    Am J Kidney Dis. 2023 Dec 29:S0272-6386(23)01000.
    PubMed         Abstract available


    BMC Neurol

  2. ZHOU Y, Chen H, Zhu M, Li M, et al
    Clinical characteristics of autoimmune encephalitis with co-existence of multiple anti-neuronal antibodies.
    BMC Neurol. 2024;24:1.
    PubMed         Abstract available

  3. POURHAJI F, Jamali J, Taraghdar MM, Peyman N, et al
    Design and validation of a Questionnaire on the factors influencing self-care behaviors in patients with Multiple sclerosis (QFASMS).
    BMC Neurol. 2024;24:20.
    PubMed         Abstract available


    Intern Med

  4. SHIBUYA R, Baba K, Furuta R, Maesaka H, et al
    A Case of Liver Cancer with Overlapping Myasthenia Gravis, Myocarditis, Seronegative Autoimmune Autonomic Ganglionopathy, and Myositis Symptoms Induced by Atezolizumab: A Case Report.
    Intern Med. 2024 Jan 2. doi: 10.2169/internalmedicine.1801.
    PubMed         Abstract available


    J Autoimmun

  5. PENG X, Li H, Zhu L, Zhao S, et al
    Single-cell sequencing of the retina shows that LDHA regulates pathogenesis of autoimmune uveitis.
    J Autoimmun. 2023;143:103160.
    PubMed         Abstract available


    J Clin Endocrinol Metab


  6. Correction to: "Ectopic Cervical Thymoma in a Patient Diagnosed With Graves Disease: A Systematic Literature Review".
    J Clin Endocrinol Metab. 2024 Jan 3:dgad759. doi: 10.1210.
    PubMed        


    J Immunol

  7. KLUG N, Burke J, Scott E
    Rational Engineering of Islet Tolerance via Biomaterial-Mediated Immune Modulation.
    J Immunol. 2024;212:216-224.
    PubMed         Abstract available

  8. HAN K, Xu J, Xie F, Crowther J, et al
    Engineering Strategies to Modulate the Gut Microbiome and Immune System.
    J Immunol. 2024;212:208-215.
    PubMed         Abstract available

  9. TOMALA J, Cao SD, Spangler JB
    Engineering Anticytokine Antibodies for Immune Modulation.
    J Immunol. 2024;212:225-234.
    PubMed         Abstract available


    J Neuroimmunol

  10. STAVROGIANNI K, Kitsos DK, Giannopapas V, Chasiotis AK, et al
    Neuropsychological profiles comparison between Multiple Sclerosis patients and Multiple Sclerosis patients with overlapping features of Systemic Lupus Erythematosus.
    J Neuroimmunol. 2023;387:578270.
    PubMed         Abstract available

  11. FUJIMORI J, Nakashima I
    Early-stage volume losses in the corpus callosum and thalamus predict the progression of brain atrophy in patients with multiple sclerosis.
    J Neuroimmunol. 2024;387:578280.
    PubMed         Abstract available

  12. BAEVA ME, Tottenham I, Koch M, Camara-Lemarroy C, et al
    Biomarkers of disability worsening in inactive primary progressive multiple sclerosis.
    J Neuroimmunol. 2023;387:578268.
    PubMed         Abstract available


    J Neurol

  13. TRYFONOS C, Chrysafi M, Vadikolias K, Berberoglou L, et al
    Nutritional interventional studies in patients with multiple sclerosis: a scoping review of the current clinical evidence.
    J Neurol. 2024 Jan 4. doi: 10.1007/s00415-023-12140.
    PubMed         Abstract available

  14. LOREFICE L, Ferraro OE, Fenu G, Amato MP, et al
    Late-onset multiple sclerosis: disability trajectories in relapsing-remitting patients of the Italian MS Registry.
    J Neurol. 2024 Jan 3. doi: 10.1007/s00415-023-12152.
    PubMed         Abstract available


    Mult Scler

  15. VENET M, Lepine A, Maarouf A, Biotti D, et al
    Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
    Mult Scler. 2024 Jan 2:13524585231223069. doi: 10.1177/13524585231223069.
    PubMed         Abstract available


    N Engl J Med

  16. LEMLEY KV, Glassock RJ
    APRIL - Springtime for New IgA Nephropathy Therapy?
    N Engl J Med. 2024;390:80-81.
    PubMed        

  17. LIU MJ, Li J
    Necrobiosis Lipoidica.
    N Engl J Med. 2024;390:70.
    PubMed        


    Neurologia (Engl Ed)

  18. ZHANG GX, Zhang WT, Gao SS, Zhao RZ, et al
    Sleep disorders in patients with multiple sclerosis in Spain.
    Neurologia (Engl Ed). 2024;39:29-35.
    PubMed         Abstract available

  19. MASKIN LP, Wilken M, Rodriguez Lucci F, Wisnivesky JP, et al
    Risk factors for respiratory failure among hospitalized patients with Guillain-Barre syndrome.
    Neurologia (Engl Ed). 2024;39:36-42.
    PubMed         Abstract available


    Neurology

  20. WU J, Guo K, Liu J
    Partially Reversible FLAIR Hyperintensity Along the Brainstem Surface in Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy.
    Neurology. 2024;102:e208064.
    PubMed         Abstract available

  21. SUNSHINE A, Mandle QJ, Cabal Herrera AM, Zapanta B, et al
    Pearls & Oy-sters: Leber Hereditary Optic Neuropathy-Plus Masquerading as Neuromyelitis Optica Spectrum Disorder in a 2-Year-Old Child.
    Neurology. 2023;101:e2585-e2588.
    PubMed         Abstract available

  22. ROLLOT F, Uhry Z, Dantony E, Vukusic S, et al
    Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality.
    Neurology. 2023;101:e2483-e2496.
    PubMed         Abstract available

  23. GALBUSERA R, Bahn E, Weigel M, Cagol A, et al
    Characteristics, Prevalence, and Clinical Relevance of Juxtacortical Paramagnetic Rims in Patients With Multiple Sclerosis.
    Neurology. 2024;102:e207966.
    PubMed         Abstract available

  24. LANGER-GOULD A, Sotirchos ES, Bourdette D
    Rituximab for Multiple Sclerosis.
    Neurology. 2024;102:e208063.
    PubMed         Abstract available

  25. HABIB AA, Sacks N, Cool C, Durgapal S, et al
    Hospitalizations and Mortality From Myasthenia Gravis.
    Neurology. 2024;102:e207863.
    PubMed         Abstract available

  26. MCGINLEY MP, Harvey T, Lopez R, Ontaneda D, et al
    Geographic Disparities in Access to Neurologists and Multiple Sclerosis Care in the United States.
    Neurology. 2024;102:e207916.
    PubMed         Abstract available

  27. ANTOZZI C, Guptill J, Bril V, Gamez J, et al
    Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis.
    Neurology. 2024;102:e207937.
    PubMed         Abstract available

  28. GIBSON S, Mcgraw C
    Teaching NeuroImage: Cryptococcus in a Woman With Multiple Sclerosis on Fingolimod.
    Neurology. 2024;102:e208027.
    PubMed         Abstract available

  29. VLAHOVIC L, McDonald J, Hinman J, Tomczak A, et al
    Prevalence, Demographic, and Clinical Factors Associated With Cognitive Dysfunction in Patients With Neuromyelitis Optica Spectrum Disorder.
    Neurology. 2024;102:e207965.
    PubMed         Abstract available

  30. CAGOL A, Benkert P, Melie-Garcia L, Schaedelin SA, et al
    Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
    Neurology. 2024;102:e207768.
    PubMed         Abstract available

  31. VIDAL-JORDANA A, Rovira A, Calderon W, Arrambide G, et al
    Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria.
    Neurology. 2024;102:e200805.
    PubMed         Abstract available

  32. TUR C, Rocca MA
    Progression Independent of Relapse Activity in Multiple Sclerosis.
    Neurology. 2024;102:e207936.
    PubMed         Abstract available

  33. GALETTA S, Brownlee W
    Assignment Completed.
    Neurology. 2024;102:e207913.
    PubMed         Abstract available


    PLoS One

  34. XUE H, Zeng L, He H, Xu D, et al
    Effects of acupuncture treatment for myasthenia gravis: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0291685.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.